이노비바(Innoviva)
US ˙ NasdaqGS ˙ US45781M1018

SecurityINVA / Innoviva, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership437,093 shares
Latest Disclosed Value $ 10,184,267
UBS Group AG ownership in INVA / Innoviva, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 437,093 shares of Innoviva, Inc. (US:INVA) valued at $10,184,267 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 508,178 shares of Innoviva, Inc.. This represents a change in shares of -13.99% during the quarter. The current value of the position is $9,685,981 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (INVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

INVA / Innoviva, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F INNOVIVA COM 45781M101 437,093 -71,085 -13.99 10,184 0.26 0.0003
2026-01-29 2025-12-31 13F INNOVIVA COM 45781M101 508,178 -64,190 -11.21 10,158 -2.75 0.0003
2025-11-13 2025-09-30 13F INNOVIVA COM 45781M101 572,368 320,499 127.25 10,446 106.42 0.0016
2025-08-14 2025-06-30 13F INNOVIVA COM 45781M101 251,869 -293,440 -53.81 5,060 -48.82 0.0009
2025-05-13 2025-03-31 13F INNOVIVA COM 45781M101 545,309 -131,160 -19.39 9,886 -15.76 0.0018
2025-02-14 2024-12-31 13F INNOVIVA COM 45781M101 676,469 368,123 119.39 11,737 97.11 0.0022
2024-11-14 2024-09-30 13F INNOVIVA COM 45781M101 308,346 29,442 10.56 5,954 30.17 0.0013
2024-08-14 2024-06-30 13F INNOVIVA COM 45781M101 278,904 -263,392 -48.57 4,574 -44.65 0.0011
2024-05-13 2024-03-31 13F INNOVIVA COM 45781M101 542,296 520,078 2,340.80 8,265 9,185.39 0.0021
2024-02-09 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 22,218 11,468 106.68 90 217.86 0.0000
2024-02-09 2023-12-31 13F INNOVIVA COM 45781M101 357,659 -268,696 5,737 0.0014
2023-11-09 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 10,750 6,520 154.14 29 -28.21 0.0000
2023-11-09 2023-09-30 13F INNOVIVA COM 45781M101 626,355 432,940 8,136 0.0028
2023-08-11 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 4,230 -2,621 -38.26 39 -35.00 0.0000
2023-08-11 2023-06-30 13F INNOVIVA COM 45781M101 193,415 -234,814 2,462 0.0008
2023-05-12 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 6,851 2,207 47.52 61 160.87 0.0000
2023-05-12 2023-03-31 13F INNOVIVA COM 45781M101 428,229 -35,563 4,818 0.0018
2023-02-08 2022-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 4,644 -17,905 -79.40 23 -91.19 0.0000
2023-02-08 2022-12-31 13F INNOVIVA COM 45781M101 463,792 441,243 6,145 0.0023
2022-11-10 2022-09-30 13F INNOVIVA COM 45781M101 22,549 -614,856 -96.46 261 -97.23 0.0001
2022-08-10 2022-06-30 13F INNOVIVA COM 45781M101 637,405 635,364 31,130.03 9,408 39,100.00 0.0039
2022-05-16 2022-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 2,041 -1,527 -42.80 24 -46.67 0.0000
2022-05-16 2022-03-31 13F INNOVIVA COM 45781M101 643,894 123,790 12,460 0.0042
2022-02-14 2021-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 3,568 -397,466 -99.11 45 -99.33 0.0000
2022-02-14 2021-12-31 13F INNOVIVA COM 45781M101 520,104 119,070 8,971 0.0026
2021-11-15 2021-09-30 13F INNOVIVA COM 45781M101 401,034 -180,453 -31.03 6,701 -14.06 0.0021
2021-08-13 2021-06-30 13F INNOVIVA COM 45781M101 581,487 -76,983 -11.69 7,797 -0.91 0.0025
2021-05-12 2021-03-31 13F INNOVIVA COM 45781M101 658,470 -183,084 -21.76 7,869 -24.53 0.0026
2021-02-11 2020-12-31 13F INNOVIVA COM 45781M101 841,554 667,417 383.27 10,427 472.91 0.0035
2020-11-12 2020-09-30 13F INNOVIVA COM 45781M101 174,137 -349,625 -66.75 1,820 -75.14 0.0007
2020-07-31 2020-06-30 13F INNOVIVA COM 45781M101 523,762 4,922 0.95 7,322 19.99 0.0031
2020-05-01 2020-03-31 13F INNOVIVA COM 45781M101 518,840 159,967 44.57 6,102 20.07 0.0029
2020-02-14 2019-12-31 13F INNOVIVA COM 45781M101 358,873 -243,468 -40.42 5,082 -19.96 0.0018
2019-11-14 2019-09-30 13F INNOVIVA COM 45781M101 602,341 367,900 156.93 6,349 86.02 0.0024
2019-08-14 2019-06-30 13F INNOVIVA COM 45781M101 234,441 -58,567 -19.99 3,413 -16.98 0.0013
2019-05-14 2019-03-31 13F INNOVIVA COM 45781M101 293,008 -77,453 -20.91 4,111 -36.41 0.0017
2019-02-14 2018-12-31 13F INNOVIVA COM 45781M101 370,461 364,488 6,102.26 6,465 7,004.40 0.0029
2018-11-14 2018-09-30 13F INNOVIVA COM 45781M101 5,973 -1,223,876 -99.51 91 -99.46 0.0000
2018-08-14 2018-06-30 13F INNOVIVA COM 45781M101 1,229,849 521,515 73.63 16,972 43.73 0.0073
2018-05-15 2018-03-31 13F INNOVIVA COM 45781M101 708,334 525,859 288.18 11,808 356.08 0.0051
2018-02-14 2017-12-31 13F INNOVIVA COM 45781M101 182,475 104,058 132.70 2,589 133.88 0.0011
2017-11-14 2017-09-30 13F INNOVIVA COM 45781M101 78,417 -93,629 -54.42 1,107 -49.75 0.0005
2017-11-14 2017-06-30 13F/A-1 INNOVIVA COM 45781M101 172,046 29,182 20.43 2,203 11.49 0.0011
2017-08-14 2017-06-30 13F INNOVIVA COM 45781M101 172,046 29,182 2,203
2017-11-14 2017-03-31 13F/A-1 INNOVIVA COM 45781M101 142,864 141,008 7,597.41 1,976 9,780.00 0.0011
2017-05-12 2017-03-31 13F INNOVIVA COM 45781M101 142,864 141,008 1,976
2017-02-14 2016-12-31 13F INNOVIVA COM 45781M101 1,856 -4,639 -71.42 20 -71.83 0.0000
2016-11-14 2016-09-30 13F INNOVIVA COM 45781M101 6,495 2,766 74.18 71 82.05 0.0000
2016-08-12 2016-06-30 13F INNOVIVA COM 45781M101 3,729 307 8.97 39 -9.30 0.0000
2016-05-12 2016-03-31 13F INNOVIVA COM 45781M101 3,422 943 38.04 43 65.38 0.0000
2016-02-16 2015-12-31 13F THERAVANCE COM 88338T104 2,479 -200 -7.47 26 36.84 0.0000
2015-11-13 2015-09-30 13F THERAVANCE COM 88338T104 2,679 -812 -23.26 19 -69.84 0.0000
2015-08-14 2015-06-30 13F THERAVANCE COM 88338T104 3,491 -273 -7.25 63 6.78 0.0000
2015-05-14 2015-03-31 13F THERAVANCE COM 88338T104 3,764 -599 -13.73 59 -3.28 0.0000
2015-02-17 2014-12-31 13F THERAVANCE COM 88338T104 4,363 4,363 61 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-12 2020-09-30 13F INNOVIVA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-31 2020-06-30 13F INNOVIVA COM Call 105,800 -78.48 1,479 -74.42 n/a n/a n/a
2020-05-01 2020-03-31 13F INNOVIVA COM Call 491,700 9.00 5,782 -9.49 n/a n/a n/a
2020-02-14 2019-12-31 13F INNOVIVA COM Call 451,100 387.15 6,388 554.51 n/a n/a n/a
2019-11-14 2019-09-30 13F INNOVIVA COM Call 92,600 -18.77 976 -22.11 n/a n/a n/a
2016-11-14 2016-09-30 13F INNOVIVA COM Call 114,000 1,253 n/a n/a n/a
2016-08-12 2016-06-30 13F INNOVIVA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-12 2016-03-31 13F INNOVIVA COM Call 116,100 1,462 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-12 2020-09-30 13F INNOVIVA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-07-31 2020-06-30 13F INNOVIVA COM Put 500,000 -15.25 6,990 0.75 n/a n/a n/a
2020-05-01 2020-03-31 13F INNOVIVA COM Put 590,000 6,938 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.